Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1708-1714

  Dorrell, Lucy ^a   Dong, Tao ^a   Ogg, Graham S ^a   Lister, Simon ^b   Mcadam, Steve ^a   Rostron, Tim ^a   Conlon, Chris ^a   Mcmichael, Andrew J ^a   Rowland Jones, Sarah L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ADULT; AFRICA; ALLOGENEIC RESTRICTION; ANTIGEN RECOGNITION; ARTICLE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL;

EID: 0032923627     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1708-1714.1999     Document Type: Article

References (31)

1. Ada, G. L., and M. J. McElrath. 1997. HIV-1 vaccine-induced cytotoxic T-cell responses: potential role in vaccine efficacy. AIDS Res. Hum. Retroviruses 13:205-210.
2. Allsopp, C. E., R. M. Harding, C. Taylor, M. Bunce, D. Kwiatkowski, N. Anstey, D. Brewster, A. J. McMichael, B. M. Greenwood, and A. V. Hill. 1992. Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am. J. Hum. Genel. 50:411-421.
3. Altman, J., P. A. H. Moss, P. Goulder, D. Barouch, M. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals. Science 274:94-96.
4. Bangham, C. R. M., and R. E. Phillips. 1997. What is required of an HIV vaccine? Lancet 350:1617-1621.
5. Betts, M. R., J. Krowka, C. Santamaria, K. Balsamo, F. Gao, G. Mulundu, C. Luo, N. N'Gandu, H. Sheppard, B. H. Hahn, S. Allen, and J. A. Frelinger. 1997. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J. Virol. 71:8908-8911.
6. Brander, C., K. E. Hartman, A. K. Trocha, N. G. Jones, R. P. Johnson, B. Korber, P. Wentworth, S. P. Buchbinder, S. Wolinsky, B. D. Walker, and S. A. Kalams. 1998. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J. Clin. Investig. 101: 2559-2560.
7. Cao, H., P. Kanki, J.-L. Sankalé, A. Dieng-Sarr, G. P. Mazzara, S. A. Kalams, B. Korber, S. Mboup, and B. D. Walker. 1997. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J. Virol. 71:8615-8623.
8. Delwart, E. L., E. G. Shpaer, J. Louwagie, F. E. McCutchan, M. Grez, H. Rubsamen Waigmann, and J. I. Mullins. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262:1257-1261.
9. Ferrari, G., W. Humphrey, M. J. McElrath, J. L. Excler, A. M. Duliege, M. L. Clements, L. C. Corey, D. P. Bolognesi, and K. J. Weinhold. 1997. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc. Natl. Acad. Sci. USA 94:1396-1401.
10. Gao, F., D. L. Robertson, S. G. Morrison, H. Hui, S. Craig, J. Decker, P. N. Fultz, M. Girard, G. M. Shaw, B. H. Hahn, and P. M. Sharp. 1996. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J. Virol. 70:7013-7029.
11. Goulder, P., C. Conlon, K. McIntyre, and A. McMichael. 1996. Identification of a novel human leukocyte antigen A26-restricted epitope in a conserved region of Gag. AIDS 10:1441-1443.
12. Goulder, P. J. R., A. K. Sewell, D. G. Lalloo, D. A. Price, J. A. Whelan, J. Evans, G. P. Taylor, G. Luzzi, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1997. Patterns of immunodominance in HIV-1 specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185:1423-1433.
13. Ikeda-Moore, Y., H. Tomiyama, K. Miwa, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Identification and characterisation of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1. J. Immunol. 159:6242-6252.
14. Janssens, W., A. Buve, and J. N. Nkengasong. 1997. The puzzle of HIV-1 subtypes in Africa. AIDS 11:705-712.
15. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512-1521.
16. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. Kerkhof Garde, R. J. Bende, I. P. Keet, J. K. Eeftinck-Schattenkerk, A. D. Osterhaus, H. Schuitemaker, and F. Miedema. 1995 Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365-1372.
17. Korber, B., B. Hahn, B. Foley, J. W. Mellors, T. Leitner, M. G. F. McCutchan, and C. Kuiken. 1997. Human retroviruses and AIDS. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N. Mex.
18. Korber, B., J. Moore, C. Brander, B. Walker, B. Haynes, and R. Koup. 1997. HIV molecular immunology database. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N. Mex.
19. Krausa, P., J. G. Bodmer, and M. J. Browning. 1993. Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens 42:91-99.
20. Lalvani, A., T. Dong, G. Ogg, A. A. Patham, H. Newell, A. V. Hill, A. J. McMichael, and S. Rowland-Jones. 1997. Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. J. Immunol. Methods 210:65-77.
21. Lynch, J. A., M. de Souza, M. D. Robb, L. Markowitz, S. Nitayaphan, C. V. Sapan, D. L. Mann, D. L. Birx, and J. H. Cox. 1998. Cross-clade cytotoxic T-cell response to HIV-1 proteins among HLA disparate North Americans and Thais. J. Infect. Dis. 178:1040-1046.
22. McAdam, S., P. Kaleebu, P. Krausa, P. Goulder, N. French, B. Collin, T. Blanchard, J. Whitworth, A. McMichael, and F. M. Gotch. 1998. Cross-clade recognition of p55 by CTL in HIV-1 infection. AIDS 12:571-579.
23. McMichael, A. J., and B. D. Walker. 1994. Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 8(Suppl. 1):S155-S173.
24. Nixon, D. F., A. R. M. Townsend, J. G. Elvin, C. R. Rizza, J. Gallwey, and A. J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484-487.
25. Ogg, G. S., J. Xin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D. D. Ho, D. F. Nixon, and A. J. McMichael. 1998. Quantitation of HIV-1-specitic cytotoxic T lymphocytes and plasma viral RNA load. Science 279:2103-2106.
26. Rinaldo, C., X.-L. Huang, Z. Fan, M, Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842.
27. Rodriguez, S. G., M. Bei, A. Inamdar, D. Stewart, A. H. Johnson, and C. K. Hurley. 1996. Molecular and serological characterization of HLA-B71 in association with different class I haplotypes or in different ethnic groups. Tissue Antigens 47:58-62.
28. Rowland-Jones, S. L., T. Dong, K. R. Fowke, J. Kimani, P. Krausa, H. Newell, T. Blanchard, K. Ariyoshi, J. Oyugi, E. Ngugi, J. Bwayo, K. S. MacDonald, A. J. McMichael, and F. A. Plummer. 1998. Cytotoxic T-cell responses to multiple conserved epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Investig. 102:1758-1765.
29. Sewell, A. K., G. C. Harcourt, P. J. Goulder, D. A. Price, and R. E. Phillips. 1997. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides. Eur. J. Immunol. 27:2323-2329.
30. Vilches, C., L. Sanz, R. de Pablo, M. E. Moreno, S. Puente, and M. Kreisler. 1996. Molecular characterization of the new alleles HLA-B*8101 and B*4407. Tissue Antigens 47:139-142.
31. World Health Organization. 1997. HIV/AIDS: the global epidemic. World Health Forum 18:369-372.